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LETTERS TO THE EDITORRELATION BETWEEN
HEMODYNAMIC BEHAVIOR
AND OCCURRENCE OF EARLY
STENOTIC FAILURE OF
BIOPROSTHESES
To the Editor:
In the May issue of the Journal,
Jamieson and Fradet1 comment on
a recent Brief Communication by Law-
ton and colleagues2 in which 4 cases of
early failure of the Mosaic (Medtronic
Inc, Minneapolis, Minn) porcine
bioprosthesis are described, with devel-
opment of severe valve stenosis neces-
sitating replacement. In their letter,
Jamieson and Fradet question the diag-
nosis of early structural valve degener-
ation (SVD) in these explants, stating
that the valves reported by Lawton
and colleagues were either thrombosed
or covered by pannus.
We recently performed long-term
clinical and echocardiographic follow-
up in a series of 564 aortic bioprostheses
(among which 152 were Mosaic valves)
with the emphasis on studying the
occurrence of structural valve deteriora-
tion as determined by echocardiogra-
phy.3 We demonstrated a link between
the presence of prosthesis–patient mis-
match (PPM) defined as an indexed ef-
fective orifice area (EOAi, cm2/m2)
less than 0.85 and the occurrence of
early, stenotic-type SVD3 with elevated
transvalvular gradients. We showed that
patients with PPM are at risk for
stenotic-type SVD, starting to occur
from 3 to 4 years after implantation. In
Lawton and colleagues’2 study, 3 of
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1200 The Journal of Thoracic andthan 0.85 and therefore had moderate
PPM. The remaining patient had an
EOAi of 0.89, which is borderline. The
observed early dysfunction in these
valves cannot be ignored, given the
reported transvalvular gradients and ef-
fective orifice areas before their explan-
tation.2 Lawton and colleagues have
made a correct observation of 4 early,
stenotic-type valve failures in patients
with moderate PPM. It might still be
that both pannus and thrombus were
present in these valves, and that these el-
ements were (partially) responsible for
the pathologic hemodynamic behavior.
But what causes such an early extensive
pannus formation or early thrombotic
changes at the surface of an aortic
bioprosthesis? As stated by Carpentier4
in his editorial on our article, a relation
between disturbed or turbulent trans-
valvular flow (as is the case when PPM
is present) and bioprosthetic tissue fail-
ure has been suspected before but was
never demonstrated. Banbury and col-
leagues5 noted a tendency for smaller bi-
oprostheses to fail earlier, but they did
not observe statistical significance in
their analysis.
In our series, none of the implanted
Mosaic valves has been explanted yet,
but 7 of the 152 Mosaic valves have
met our (echocardiography-based) cri-
teria for stenotic-type SVD on follow-
up echocardiography. The earliest was
already observed after 2.5 years after
implantation. Six of these patients
had moderate PPM (EOAi range
0.66–0.82), and the remaining patient
had an EOA index of 0.88. PPM might
not be harmful for the patient, but for
the valve..
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This communication is in re-
sponse to the Letter to the Editor by
Meuris and Flameng1 in response to
our Letter to the Editor2 commenting
on the brief communication by Lawton
and colleagues.3 We identified that
Lawton and colleagues misrepresented
thrombosis and pannus (nonstructural
dysfunction) as durability issues.
Meuris and Flameng1 are challenging
our judgment and stating that Lawton
and colleagues3 ‘‘have made a correct
observation of four early, stenotic-type
valve failures in patients with moderate
PPM.’’ We also stated ‘‘the radiographs
were reported as part of the pathological
reports, showing no mineralization of
valve tissue in three and remnants of
mineralization of host tissue on the sew-
ing ring of the other prosthesis.’’ We
have reviewed all the documentation, in-
cluding the radiographs, and stand with
our original report.
Meuris and Flameng’s concern is re-
lated to evidence recently published by
Flameng and colleagues.1,4 These
investigators evaluated the relationship
of structural valve degeneration (SVD)
and prosthesis–patient mismatch
(PPM) (indexed effective orifice area
[EOAi] to body surface area with
known referenced effective orifice areas
by prosthesis size). They found no rela-
tionship to survival for the level of
EOAi, the same lack of influence as
we found,5 but PPM less than 0.85
cm2/m2 is predictive of SVD (hazard10
